XP disease, formally called xeroderma pigmentosum, is a rare inherited condition in which the body cannot repair DNA damage caused by ultraviolet (UV) light. People with XP are up to 10,000 times more likely to develop skin cancer than the general population, and the first skin cancer typically appears before age 10. The condition affects roughly 1 in 250,000 people in the United States and Europe, with higher rates in Japan.
How XP Affects the Body
Every time UV light hits your skin cells, it damages small segments of DNA. In healthy cells, a built-in repair system called nucleotide excision repair finds and fixes that damage almost immediately. In people with XP, mutations in one of several genes cripple this repair system. The damaged DNA never gets corrected, and it accumulates over a lifetime of even minimal sun exposure.
That accumulation is what drives the disease. Unrepaired DNA errors cause cells to grow abnormally, leading to precancerous spots, skin cancers, and damage to the eyes and, in some cases, the nervous system. XP is inherited in an autosomal recessive pattern, meaning a child must receive a faulty copy of the same gene from both parents to develop the condition.
The Eight Genetic Types
XP isn’t a single disease. There are seven complementation groups (labeled XPA through XPG) plus a variant form called XPV. Each type involves a mutation in a different gene along the DNA repair pathway. The type matters because it determines how much repair capacity remains and how severe the disease is likely to be.
XPA and XPC are the most common forms. XPA, particularly prevalent in Japan, leaves cells with less than 2% of normal repair function and almost always involves neurological problems. XPC retains about 10 to 25% of normal repair and generally spares the nervous system but still carries extreme cancer risk. XPD retains 25 to 55% of normal repair but often includes neurological involvement. The variant form, XPV, involves a different part of the DNA copying process rather than the main repair pathway, and tends to be milder.
Early Signs and Skin Symptoms
The earliest warning sign is usually an extreme sunburn reaction. Some children with XP blister severely after just a few minutes of sun exposure. Others don’t burn dramatically but develop unusually dense freckling on sun-exposed areas of the face, arms, and neck within the first two years of life. These freckle-like spots appear much earlier and in greater numbers than typical childhood freckles.
Over time, the skin in sun-exposed areas becomes dry, thin, and mottled with light and dark patches. Precancerous growths begin to appear, followed by skin cancers. People with XP are 10,000 times more likely to develop non-melanoma skin cancers (basal cell and squamous cell) and up to 2,000 times more likely to develop melanoma compared to unaffected individuals.
Eye and Vision Problems
The eyes are highly vulnerable because the surface of the eye receives direct UV exposure. Common findings include extreme light sensitivity, chronic inflammation of the whites of the eyes, and abnormal tissue growths on the eye surface. Over time, the cornea can become scarred or clouded, impairing vision. Cancers can also develop on the eyelids and the surface of the eye itself.
In one long-term study, 85% of XP patients who were first seen at age 10 or younger already had some degree of eye damage. Protective wraparound sunglasses that block both UVA and UVB, including side shields, are considered essential from infancy.
Neurological Complications
About 39% of XP patients develop neurological symptoms, though this varies dramatically by genetic type. More than half of people with XPA, XPD, or XPG experience neurological problems, while those with XPE or XPV are typically spared entirely.
Neurological symptoms usually appear after skin and eye problems are already established. The most common early signs are problems with balance, developmental delays in children, cognitive difficulties, and hearing loss. Hearing impairment affects about 30% of all XP patients. As the disease progresses, brain and nerve degeneration can cause involuntary movements, difficulty with eye coordination, and loss of reflexes. Brain imaging often shows shrinkage of the cerebellum (the region controlling coordination) and broader brain atrophy. In people with XPD, balance and coordination scores worsen by a measurable amount each year, reflecting steady neurological decline.
How XP Is Diagnosed
XP is often suspected based on clinical signs: an unusual sunburn reaction in infancy, early freckling, or a first skin cancer in childhood. Confirmation requires genetic testing to identify which of the eight XP genes carries the mutation. Specialized lab tests can also measure how well a patient’s cells repair UV-damaged DNA, which helps determine the complementation group and predict severity. Prenatal testing and carrier screening are available for families with a known history of the condition.
Daily Life With XP
There is no cure for XP. Management centers on rigorous, lifelong UV avoidance, which can dramatically reduce cancer development and slow skin damage. This goes far beyond applying sunscreen before going outside. It means restructuring daily life around UV exposure.
UV-blocking film can be applied to every window in the home and car. The film doesn’t need to be darkly tinted, since UV light is invisible. Indoor lighting matters too: fluorescent and halogen bulbs emit small amounts of UV, so replacing them with LED or incandescent bulbs, or covering fluorescent tubes with plastic UV-blocking sleeves, reduces indoor exposure. Portable UV meters allow patients and families to measure UV levels in any environment, identifying hidden sources of exposure.
Outdoors, full-coverage clothing is necessary. Long sleeves, long pants, gloves, closed-toe shoes with socks, and wide-brimmed hats with attached UV-blocking face shields form the standard outfit. The fabric itself matters: dense, tightly woven, darker materials like denim and polyester block more UV. A quick test is to hold fabric up to a light source. If visible light passes through the weave, UV is getting through too. Specialty UV-protective clothing treated with UV absorbers is commercially available, and laundry rinses can add UV-blocking properties to regular clothes.
Sunscreen with SPF 15 or higher is recommended for any skin that remains exposed, with physical sunscreens containing zinc oxide or titanium dioxide preferred because they block a broader spectrum of radiation. For the eyes, wraparound sunglasses with full UVA and UVB protection, including side shields, are used daily. Artificial tears help manage chronic dryness and irritation.
Cancer Prevention and Treatment
Even with strict sun protection, regular skin checks are essential. Dermatologists typically examine XP patients every few months to catch precancerous spots and early skin cancers. Cancers that do develop are treated surgically, just as they would be in the general population, but they occur far more frequently and at much younger ages.
For patients who develop many new skin cancers despite protection, oral retinoids (a class of vitamin A-related medication) can reduce the rate of new tumor formation. This treatment carries significant side effects and is generally reserved for the most severely affected individuals. In one clinical trial, a specially formulated lotion containing a DNA repair enzyme reduced the annual rate of new precancerous skin spots from about 26% to 8% in XP patients, though this treatment is not widely available.
Prognosis and Life Expectancy
Life expectancy for people with XP depends heavily on the genetic type, the severity of cancer development, and how rigorously UV exposure is controlled. Those with milder forms like XPC or XPV, who begin strict photoprotection early in life, can live well into adulthood. Patients with XPA or other types involving severe neurological degeneration face a more difficult course, as progressive brain and nerve damage compounds the cancer burden. The leading causes of death are metastatic skin cancer and, in those with neurological involvement, complications of progressive neurodegeneration. Early diagnosis and aggressive sun protection from infancy remain the most effective ways to extend both lifespan and quality of life.